Andrew Callos, Executive Vice President and Chief Commercial Officer at Cytokinetics INC (NASDAQ:CYTK), sold a total of 26,000 shares of common stock on March 5, 2026, for approximately $1.6 million.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results